Literature DB >> 19067230

Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx.

P L Calvo1, S Pagliardini, M Baldi, A Pucci, L Sturiale, D Garozzo, T Vinciguerra, C Barbera, J Jaeken.   

Abstract

A 32 year-old asymptomatic male came to our attention with a 21-year history, documented elsewhere, of puzzling increases in his serum transaminase level. At first, very low serum ceruloplasmin level suggested Wilson disease. Two liver biopsies showed mild portal inflammation, steatosis and mild fibrosis. Further investigation revealed low levels of the glycoproteins AT III and clotting factor XI, leading to a diagnosis of congenital disorder of glycosylation (CDG) type II. Further studies as to the cause of this 'apparently new' CDG, are ongoing. On the basis of our data and a literature review, we suggest that subjects with asymptomatic hypertransaminasaemia be screened for CDG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067230     DOI: 10.1007/s10545-008-1004-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

Review 1.  Congenital disorders of glycosylation (CDG): update and new developments.

Authors:  J Jaeken
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation.

Authors:  Claudia Mandato; Lena Brive; Yoshiaki Miura; Joseph Alex Davis; Nicolina Di Cosmo; Stefania Lucariello; Severo Pagliardini; Neung-Seon Seo; Giancarlo Parenti; Raffaella Vecchione; Hudson H Freeze; Pietro Vajro
Journal:  Pediatr Res       Date:  2006-02       Impact factor: 3.756

3.  NASH may be trash.

Authors:  David Cassiman; Jaak Jaeken
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

4.  Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation.

Authors:  J Jaeken; G Matthijs; J M Saudubray; C Dionisi-Vici; E Bertini; P de Lonlay; H Henri; H Carchon; E Schollen; E Van Schaftingen
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

5.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.

Authors:  P de Lonlay; N Seta; S Barrot; B Chabrol; V Drouin; B M Gabriel; H Journel; M Kretz; J Laurent; M Le Merrer; A Leroy; D Pedespan; P Sarda; N Villeneuve; J Schmitz; E van Schaftingen; G Matthijs; J Jaeken; C Korner; A Munnich; J M Saudubray; V Cormier-Daire
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

6.  Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.

Authors:  R Niehues; M Hasilik; G Alton; C Körner; M Schiebe-Sukumar; H G Koch; K P Zimmer; R Wu; E Harms; K Reiter; K von Figura; H H Freeze; H K Harms; T Marquardt
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

7.  Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.

Authors:  Gerard Damen; Hans de Klerk; Jan Huijmans; Jan den Hollander; Maarten Sinaasappel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

Review 8.  Deficiencies in subunits of the Conserved Oligomeric Golgi (COG) complex define a novel group of Congenital Disorders of Glycosylation.

Authors:  Renate Zeevaert; François Foulquier; Jaak Jaeken; Gert Matthijs
Journal:  Mol Genet Metab       Date:  2007-09-29       Impact factor: 4.797

Review 9.  Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond.

Authors:  Hudson H Freeze
Journal:  Curr Mol Med       Date:  2007-06       Impact factor: 2.222

Review 10.  Congenital disorders of glycosylation--a challenging group of IEMs.

Authors:  J Vodopiutz; O A Bodamer
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

View more
  4 in total

1.  An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia.

Authors:  Pier Luigi Calvo; Marco Spada; Ivana Rabbone; Michele Pinon; Francesco Porta; Fabio Cisarò; Stefania Reggiani; Angelo B Cefalù; Luisella Sturiale; Domenico Garozzo; Dirk J Lefeber; Jaak Jaeken
Journal:  JIMD Rep       Date:  2017-06-23

Review 2.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

3.  TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation.

Authors:  Jos C Jansen; Sharita Timal; Monique van Scherpenzeel; Helen Michelakakis; Dorothée Vicogne; Angel Ashikov; Marina Moraitou; Alexander Hoischen; Karin Huijben; Gerry Steenbergen; Marjolein A W van den Boogert; Francesco Porta; Pier Luigi Calvo; Mersyni Mavrikou; Giovanna Cenacchi; Geert van den Bogaart; Jody Salomon; Adriaan G Holleboom; Richard J Rodenburg; Joost P H Drenth; Martijn A Huynen; Ron A Wevers; Eva Morava; François Foulquier; Joris A Veltman; Dirk J Lefeber
Journal:  Am J Hum Genet       Date:  2016-01-28       Impact factor: 11.025

Review 4.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.